CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 30 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,826 | -45.1% | 16,424 | -8.8% | 0.00% | – |
| Q2 2023 | $10,609 | -15.3% | 18,009 | -18.0% | 0.00% | – |
| Q1 2023 | $12,528 | -21.9% | 21,960 | -8.7% | 0.00% | – |
| Q4 2022 | $16,048 | -83.6% | 24,060 | -64.3% | 0.00% | – |
| Q3 2022 | $98,000 | -38.4% | 67,340 | +122.8% | 0.00% | – |
| Q3 2021 | $159,000 | -43.0% | 30,221 | -35.8% | 0.00% | -100.0% |
| Q2 2021 | $279,000 | +206.6% | 47,070 | +266.2% | 0.00% | – |
| Q1 2021 | $91,000 | – | 12,855 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 462,659 | $1,411,000 | 0.58% |
| Sio Capital Management, LLC | 422,598 | $1,289,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 508,322 | $1,550,000 | 0.22% |
| Affinity Asset Advisors, LLC | 400,000 | $1,220,000 | 0.20% |
| Atom Investors LP | 31,385 | $96,000 | 0.04% |
| Ikarian Capital, LLC | 104,741 | $319,000 | 0.04% |
| Schonfeld Strategic Advisors LLC | 514,780 | $1,570,000 | 0.01% |
| PURA VIDA INVESTMENTS, LLC | 77,568 | $237,000 | 0.01% |
| Point72 Asset Management, L.P. | 230,000 | $702,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 58,934 | $179,000 | 0.00% |